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ABSTRACT
The present study investigated the effects of transcranial direct current stimulation
(tDCS) on maximal voluntary contraction strength (MVC) and the time to failure (TTF)
of an isometric muscle endurance test of the elbow flexors. Prior to the main study, the
test-retest reliability of MVC and TTF measures was investigated using 10 men (33.2 ±
9.4 y) for the measurements separated by 60 min (within-day) and one week (betweenday). Coefficient of variation (CV), Intraclass correlation (ICC, R), a paired t-test and
the Bland-Altman plots revealed that TTF at 30% MVC task was reliable, and was able
to detect a possible effect of tDCS on TTF, if the magnitude of effect was greater than
11%. Based on the reliability study results, it was hypothesised that tDCS would
increase TTF from the first test to the second test separated by 60 min, when a tDCS
treatment was administered immediately before the second test. Fifteen men (27.7 ± 8.4
y) were tested for MVC and TTF at 30%-MVC before and immediately after tDCS or
sham intervention (10 min) in three separate sessions. In two sessions direct current (2
mA) was delivered through saline-soaked sponge electrodes, with the anode placed on
the scalp overlying the right motor cortical representation of the left arm and the
cathode secured over the right shoulder. One session was a sham intervention (current
delivery for the first 30s). The order of the intervention sessions was randomised and
counterbalanced amongst the subjects and subjects who were blinded to intervention
type. Changes in MVC strength and TTF from pre to post intervention were compared
between the interventions by a two-way repeated measures ANOVA. No significant
differences were evident for the two tDCS sessions. MVC strength (baseline: 66.0 ±
11.4 Nm) decreased by 5.9 ± 4.2 % (P<0.05) in the post-intervention measures, but no
significant difference in the changes was evident between sham and tDCS interventions.
TTF did not change significantly from pre (309.2 ± 91.6 s) to post intervention (327.2 ±
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128.5 s), and no significant difference was found between interventions. In conclusion,
tDCS did not affect TTF and MVC of the elbow flexors. It appears that the tDCS
intervention did not affect cortical excitability due to ceiling effects that made it unable
to modulate voluntary activation of motor units. Since the present study did not assess
motor evoked potentials (MEP) that could show changes in cortical excitability
following tDCS or sham treatment, further studies are required to examine the effects of
tDCS on cortical excitability.
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CHAPTER 1
INTRODUCTION
1.1 Background
Transcranial direct current stimulation (tDCS) is a method of altering cortical
excitability using low intensity (1~2 mA) direct current delivered to the scalp overlying
a target region of the brain via surface electrodes connected to a controlled currentgenerating unit (Jeffrey et al. 2007). tDCS modulates cortical excitability (Nitsche and
Paulus 2000; Paulus 2004) by altering the motor unit firing rates due to a shift of resting
membrane potentials of cortical neurons (Purpura and McMurtry 1965). tDCS has been
used clinically in reducing pain (Fregni et al. 2006; Csifcsak et al. 2009), treatment for
depression (Boggio et al. 2008a) and improving dexterity following stroke (Hummel et
al. 2005; Boggio et al. 2007).
Cortical excitability changes induced by tDCS are dependent on the current
polarity (anodal/cathodal), intensity and duration of the stimulation (Nitsche and Paulus
2000). It has been consistently shown that anodal stimulation over the motor cortex
increases corticomotor excitability which is indicated by an increase in amplitude of
motor evoked potentials (MEP) induced by transcranial magnetic stimulation (TMS)
applied over the same cortical site; by contrast cathodal stimulation decreases cortical
excitability (Liebetanz et al. 2002; Nitsche et al. 2007; Nitsche and Paulus 2000; Power
et al. 2006). It has been shown that as little as 5-min anodal stimulation of the motor
cortex using a low intensity 1mA current affects MEP amplitude by 30-40% for 5min
following stimulation (Nitsche and Paulus 2000), whereas the effects of doubling this
current intensity 2 mA and applying for a slightly longer duration (7-10min) can
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enhance cortical excitability for 60 min following stimulation and increasing MEP
amplitude by 40% (Jeffrey et al. 2007; Nitsche et al. 2005).
Application of tDCS has also shown increases in neuronal activation in motor
cortex and interconnected areas of motor circuits and pathways as indicated by
enhanced blood-oxygen level dependency Functional magnetic resonance imaging
(fMRI) studies (Jang et al. 2009). Furthermore, anodal tDCS of motor cortex also
increases spinal network excitability, for example stimulation of hand area of motor
cortex increases disynaptic inhibition directed from extensor carpi radialis (ECR) to
flexor carpi radialis (FCR) with no modification of presynaptic inhibition of FCR Ia
terminals and no change to FCR Hoffmann reflex (H-reflex) recruitment curves,
indicating that anodal stimulation of motor cortex increases disynaptic interneuron
excitability in spinal networks (Roche et al. 2009). Recent studies have shown
improvement in outcomes after applying anodal tDCS over regions controlling hand
motor function such as dexterity tasks and pinch forces in stroke rehabilitation
(Hummel et al. 2009) and also with regions controlling leg motor pinch forces (Jeffrey
et al. 2007; Tanaka et al. 2009).
To the best of our knowledge, only one study (Cogiamanian et al. 2007) has
reported the effects of tDCS on muscle function. The study compared the effects of
tDCS intervention (n=9) and no intervention (control: n=15) on a time to failure (TTF)
in a submaximal (35% maximal voluntary contraction strength: 35% MVC) isometric
contraction task of the elbow flexors using 24 healthy men (n=10) and women (n=14).
The participants in the intervention group received anodal and cathodal tDCS (1.5 mA)
for 10 min in random order (with a week separating each session) before the second
muscle endurance test (50 min after the first test). The control group had the second
muscle endurance test without tDCS at 60 min after the first test. The study found that
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the TTF decreased significantly in the second test compared with the first test for both
groups; however, the magnitude of the decrease in TTF was significantly smaller (20%)
for the anodal tDCS intervention compared with the cathodal tDCS intervention (35%)
and the control conditions (30%). From this the authors concluded that anodal tDCS
was effective in improving muscle endurance.
Our pilot study data showed no significant changes in TTF in a sustained
submaximal (30% MVC) isometric contraction task from the first to the second test
separated by a 60-min rest. This is contrary to the aforementioned study (Cogiamanian
et al., 2007) which reported a decrease in TTF in the second test. In order to confirm the
pilot study results, and examine the test-retest reliability of the TTF and MVC measures,
further study is necessary to compare between two tests separated by 60 min or one
week for both TTF and MVC.
Whilst the aforementioned study used both male and female participants, gender
difference in endurance and fatigability exists. It has been reported that women are less
fatigable and have longer endurance time than men (Hunter et al. 2006; Hunter and
Enoka 2001). Furthermore, two studies have reported gender differences in responses to
tDCS (Chaieb et al. 2008; Kuo et al. 2006). Thus, it may be that the effect of tDCS
treatment on muscle function particularly strength endurance, differs between men and
women. The previous study (Cogiamanian et al., 2007) compared two different groups
of male and female participants. It should be also noted that a large variability exists in
the muscle endurance time amongst individuals. Testing participants of the same gender
only for both tDCS and control conditions in a crossover manner may be a more
appropriate design. It is also possible that a higher tDCS intensity (e.g. 2 mA) affects
muscle function greater than the current intensity used in the previous study (1.5 mA).
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1.2 Purpose of the Study
Therefore the present study investigated the reliability of MVC and TTF test at 30%
MVC for the measurements separated by 60 min (within-day) and one week (betweenday) in STUDY 1. In STUDY 2, the hypothesis that anodal tDCS (2 mA) intervention
applied over the motor cortex for 10 min would increase TTF and MVC strength of the
elbow flexors in comparison to a sham intervention using men only in a randomised,
crossover design.
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CHAPTER 2
METHODS
2.1 Study 1 - Reliability of time to failure muscle endurance tests at
submaximal intensity for the elbow flexors
2.1.1 Experimental design
The present study consisted of one familiarisation and two experimental sessions,
each session scheduled one week apart. In the familiarisation session, participants
performed five MVC contractions (2 s) followed by three practice contractions at 30%
MVC and one TTF task of the elbow flexors using the left arm. As shown in Figure 1,
all participants performed a set of measurements consisting of MVC, 10 s isometric
contraction at 30% MVC, and isometric contraction time to failure test at 30% MVC
twice separated by a 60-min rest to examine the within-day reliability. The same
protocol was repeated one week later to examine the between-day reliability. All tasks
involved only the non-dominant (left) arm.

5

Figure 1: Measurement protocol. The measurement protocol consisted of two trials
(Trial 1 and Trial 2) performed 60 min apart. During each trial, participants performed
3 maximal voluntary contraction (MVC) for 2 s with a 60-s rest between contractions to
determine MVC followed a 3-min rest by 3 sustained (10 s) isometric contractions at 30%
MVC with a 60-s rest between contractions, then after a 3-min rest by a time to failure
(TTF) isometric contraction endurance task at 30% MVC. This entire protocol was
repeated one week later.

2.1.2 Participants
Ten healthy men (mean ± SD age, height, and weight: 33.2 ± 9.4 y, 177.2 ± 8.1
cm, 77.4 ± 14.4 kg, respectively) participated in the present study. All participants were
right hand dominant based on handedness test (Oldfield 1971). They completed a
medical questionnaire to screen for neuromuscular disorders, musculoskeletal disorders
or injuries apparent in the upper body, or the presence of other medical conditions
known to affect muscle endurance (e.g. chronic fatigue syndrome). They signed an
6

informed written consent form before participating in the study. The participants were
prohibited consumption of caffeine four hours prior to the testing, as it is reported that
ingestion of caffeine may influence rating of perceived exertion during submaximal
exercise task (Doherty et al. 2004). Participants were also advised not to engage in any
physical activity 24 hrs prior to the experimental sessions. Ethical approval from the
Human Research Ethics Committee of Edith Cowan University was obtained prior to
commencement of the study.

2.1.3 MVC and muscle endurance tests
Participants were seated on a preacher curl bench by securing the shoulder joint
angle at 45º flexion. The forearm of the left arm was kept supinated and the elbow joint
angle was set at 90º with the joint aligned with the axis of rotation of a Cybex 6000
Isokinetic Dynamometer (Lumex Inc. Ronkonkoma, USA) (Figure 2). Torque output of
the elbow’s movement and contractions were collected onto a data acquisition system
(PowerLab16, ADInstruments, Bella Vista, Australia) at a sampling rate of 2000 Hz,
and real-time visual feedback of torque signals were displayed on a computer monitor.
Although the generic torque output levels were displayed, actual torque values and
duration of contractions were not shown, thus participants were blinded to actual values
of output.
2.1.3.1 MVC test
MVC torque was determined by the mean of the peak torque of three MVC trials
(2 s each) with a 3-min rest between trials.
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2.1.3.2 TTF test
TTF was determined by the point in time whereby participants were unable to
maintain 90% of the target torque for more than 2 s, in spite of continual verbal
ncouragement (Yue et al. 1997) (Figure 3).

Figure 2: Experimental setup for participants. The maximal voluntary isometric
contraction strength at the elbow joint of 90° (MVC) and time to failure (TTF) isometric
task at 30% MVC. This shows the limb posture, positioning of the arm (90 °) with
forearm supinated, when performing the required contractions.
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Figure 3: An example of torque output during a time to failure (TTF) task for a
participant. The time started when the torque exceeds the target (22.3 Nm in this case)
and ended when a participant was not able to maintain the target and the torque output
decreased more than 10% of the target torque (20 Nm in this case) for more than 2 s
consecutively. The TTF was 151.2 s for this subject.
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2.2 Study 2 - Effect of transcranial direct current stimulation (tDCS)
on maximal voluntary isometric strength and endurance of the elbow
flexors
2.2.1 Experimental design
The present study consisted of one familiarisation and three experimental sessions,
each session conducted one week apart. All tasks involved only the non-dominant arm,
which was the left arm for all participants. In the familiarisation session, participants
performed five MVC contractions (2 s) followed by three practice contractions at 30%
MVC and one TTF task of the elbow flexors using the left arm and at the end of the
session sham tDCS intervention (see below) was applied for 10-min (Figure 4).
All subjects participated in three experimental sessions separated by a week; two
sessions employed a tDCS intervention and one session employed a sham intervention.
Each experimental session consisted of pre and post intervention measures and a 10-min
intervention. As shown in Figure 4, the measurements consisted of three MVC followed
by a 3-min rest, thereafter performing three 10-s isometric contractions at 30% MVC.
Following another 3-min of rest, a TTF isometric contraction at 30% MVC was
measured. This protocol was repeated 60-min later, and participants remained awake
and interactive during the rest period. During the last 10-min of the 60-min rest, either a
sham or tDCS intervention was administered. All participants were blinded to the type
of intervention administered and outcomes of TTF task. The order for intervention
conditions was randomised and counterbalanced among the participants such that the
sham intervention and tDCS intervention was arranged either Sham-tDCS-tDCS, tDCSSham-tDCS or tDCS-Sham-tDCS, with 5 participants for each sequence.
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Figure 4: Experimental design and measurement protocol. Participants performed 3
maximal voluntary contractions (MVC) for 2 s with a 60-s rest between trials to
determine the baseline MVC torque for the following 3 sustained (10 s) isometric
contractions at 30%-MVC with a 60-s rest in between, and the time to failure isometric
contraction endurance test (TTF) at 30%-MVC, with a 3-min rest period between each
stage of testing. The whole protocol was repeated 60-min later (Post), with either tDCS
or sham intervention (10-min) administered at 50-min after the baseline measures (Pre).

2.2.2 Participants
Fifteen healthy men (mean ± SD age, height, and weight: 27.7 ± 8.4 y, 176.4 ± 7.4
cm, 72.7 ± 8.7 kg, respectively) participated in the present study. All of them were
right-hand dominant based on the Edinburgh Handedness Inventory (Oldfield, 1971).
They completed a medical questionnaire to screen for neuromuscular and
musculoskeletal disorders or injuries of the upper body, or the presence of other medical
conditions known to affect muscle endurance (e.g. chronic fatigue syndrome), and the
participants who had any of these were excluded from the study. They signed an
11

informed written consent form before participating in the study. The participants were
prohibited consumption of caffeine four hours prior to the testing, since it has been
reported that ingestion of caffeine influences rating of perceived exertion during
submaximal exercise task (Doherty et al. 2004). Ethical approval from the Human
Research Ethics Committee of Edith Cowan University was obtained prior to
commencement of the study, and the study was conducted in conformity with the
Declaration of Helsinki.

2.2.3 tDCS and Sham interventions
An Eldith direct current stimulator (Neuroconn, Ilmenau, Germany) was used in
the present study, which delivered constant direct current (2 mA) through a pair of 0.3
cm thick square (24 cm2) sponge electrodes (Figure 5). The anode electrode was placed
on the scalp overlying the right hemisphere motor cortical representation of the left arm,
and the cathode was placed over the contralateral shoulder (Figure 5) based on the
method described by (Cogiamanian et al., 2007). The sham intervention was identical to
the tDCS intervention, except that the current was programmed to return to zero for the
remaining time period after 30 s of stimulation (Boggio et al., 2008b; Vines et al., 2008).
Rubber electrodes were kept constantly wet with saline solution in order to prevent heat
from building up as well as to aid conductivity (Figure 6). Safety standards were in
accordance with the limits discussed by Bikson et al. (2009). Apart from a slight
tingling sensation below electrodes as reported by Dundas et al. (2007) no other side
effects were expected.
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Figure 5: tDCS and sham intervention electrode placement and protocol. A participant
sit on an arm curl bench, and a pair of 6 x 4 cm rubber electrodes were placed on the
region overlying motor cortex controlling the left elbow flexor muscles (anode) and
ipsilateral shoulder (cathode). The current was delivered through the Eldith Direct
Current Stimulator.

Figure 6: Administration of saline solution on the electrode covered by sponge.
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2.2.4 MVC and muscle endurance tests
In a similar way to those explained in STUDY 1, participants were seated on a
preacher curl bench by securing the shoulder joint angle at 45º flexion (Figure 1). The
forearm of the left arm was kept supinated and the elbow joint angle was set at 90º with
the joint aligned with the axis of rotation of a Cybex 6000 isokinetic dynamometer
(Lumex Inc. Ronkonkoma, USA) operated by a HUMAC system (CSMI Medical
Solutions, Massachusetts, USA) installed on a personal computer (Lenovo Think Center,
IBM, New York, USA). Torque signals were collected onto a data acquisition system
(PowerLab16, ADInstruments, Bella Vista, Australia) at a sampling rate of 2000 Hz,
and real-time visual feedback of torque signals were displayed on the computer monitor.
Although the torque output levels were displayed on the monitor to show the trace of
the torque in relation to the target torque, actual torque values of MVC test and duration
of contractions in the muscle endurance test were not informed to the participants. MVC
was determined by taking the mean torque of the three MVC trials, and the 30% MVC
was set based on the MVC measures immediately before each TTF test. The TTF was
determined by the time point in which participants were unable to maintain greater than
90% of the target torque output for more than 2 s (Figure 3), in spite of continual verbal
encouragement (Yue et al. 1997).
2.2.5 Surface electromyography (EMG) and torque fluctuation
Biceps brachii muscle activity was recorded by EMG using pre-gelled 20-mm
diameter Ag-AgCl disposable electrodes (Uni-Patch, Wasbasha, Minnesota, USA)
placed 2 cm apart over the mid-belly of the biceps brachii and triceps brachii of the left
arm in bipolar configuration. EMG signals were amplified and band-pass filtered (5 Hz1 kHz) using an data acquisition system (PowerLab16 with Chart 6 software,
14

ADInstruments, Bella Vista, Australia) recorded at a sampling rate of 2000 Hz. EMG
activity during the last 3 s of the third 10-s 30%-MVC sustained isometric task was
analysed for root mean square (RMS) amplitude at every 1 s interval. Using the same
time period as the EMS analysis, fluctuation of torque during the 3 s was quantified as a
coefficient of variation of the torque (CV = SD/mean x 100) according to a previous
study (Lavender and Nosaka, 2006) (Figure 7).

Figure 7: Analysis of torque fluctuation and electromyography root-mean-square (EMG
RMS) values for the last 3 s of 10 s sustained isometric contraction at 30% MVC.
Torque fluctuation was sampled over the 3 s block calculating the coefficient of
variation (CV = SD/mean x 100). RMS was calculated with every 1 s block of data
across the 3 s.
2.2.6 Pain perception
Participants reported their pain perception levels before and immediately after
performing the TTF task according to a modified version of the CR-10 scale, in which 1
indicated “no pain at all” and 10 indicated “extreme pain.”
15

2.2.7 Statistical Analysis
MVC strength, TTF, RMS amplitude, CV for torque fluctuation and pain
perception were compared between the baseline and the post-intervention measures for
each session (two tDCS intervention sessions: tDCS 1 and tDCS 2, and one sham
intervention session) by a paired t-test. The Mauchly's Test of Sphericity was conducted
to ensure normality of the data collected. A two-way repeated measures analysis of
variance (ANOVA) was used to compare the changes in these variables from baseline to
post-intervention measures among the three sessions, and between sham and tDCS 1,
sham and tDCS 2, and tDCS 1 and tDCS 2, separately. For all analyses, a Predictive
Analytics Software (PASW) for Windows (Version 18.0) was used.

Statistical

significance was accepted at P≤ 0.05. The results are shown in mea n ± SD unless
otherwise stated.
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CHAPTER 3
RESULTS
3.1 Study 1 - Reliability of time to failure muscle endurance tests at
submaximal intensity for the elbow flexors
3.1.1 Within-day reliability
Table 1 shows within-day reliability based on the combined outcomes over 2
weeks (n=20) of measurements (Trial 1 and Trial 2) separated by 60-min for MVC and
TTF measures. A significant decrease (5.9 ± 4.2 %) in MVC was evident from Trial 1 to
Trial 2. However, CV and ICC R showed that the test-retest reliability of the MVC
measure was good. Regarding the TTF, no significant difference was found between
Trial 1 and 2, and CV and ICC R showed that the test-retest reliability was acceptable.

Table 1: Within-day reliability for maximal voluntary isometric contraction strength at
90° elbow flexion (MVC) and time to failure (TTF) of isometric contraction sustained
task at 30% MVC. Trial 1 and Trial 2 were separated by 60-min. The results of paired ttest to compare between Trial 1 and Trial 2, and coefficient of variation (CV) and Intraclass correlation (ICC, R) based on the two trials are shown.

Trial 1

Trial 2

Paired TTest (P)

CV (%)

ICC (R)

MVC (Nm)

64.4 ± 20.3

61.2 ± 19.7

0.000

4.3

0.99

TTF (s)

334.4 ± 132.3

309.8 ± 94.3

0.119

10.9

0.84
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3.1.2 Between-day reliability
Between-day reliability was based on Trial 1 measurements taken one week apart.
A significant decrease (5.9 ± 5.0%) in MVC was evident from Week 1 to Week 2.
However, CV and ICC R showed that the test-retest reliability of the MVC measure was
good. Regarding the TTF, no significant difference was found between Week 1 and
Week 2, and CV and ICC R showed that the test-retest reliability was acceptable.

Table 2: Between-day reliability for maximal voluntary isometric contraction strength
at 90° elbow flexion (MVC) and time to failure (TTF) of isometric contraction sustained
task at 30% MVC. Week 1 and Week 2 were separated by one week. The results of
paired t-test to compare between Week 1 and Week 2, and coefficient of variation (CV)
and Intra-class correlation (ICC, R) based on the two measures from Week 1 and Week
2 are shown.

Week 1

Week 2

Paired TTest (P)

CV (%)

ICC (R)

MVC (Nm)

66.6 ± 21.0

62.1 ± 20.4

0.000

5.9

0.987

TTF (s)

319.7 ± 113.8

347.11 ± 153.6

0.174

9.4

0.906
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3.1.3 Bland Altman Plots
Figure 8 shows Bland-Altman plots for MVC and TTF. Although there are some
outliers, most of the plots are located within the 2 SD limits of agreement.

Difference (Nm)
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Figure 8: Bland-Altman plots for MVC and TTF based on the two measurements taken
60-min apart. Every plot represents the difference vs. mean value measured during the
testing session (Day 1 and Day 2). Straight lines represent the mean difference (central
line) and mean ± 2 SD (depicted by both upper and lower dotted lines).

3.2 Study 2 - Effect of transcranial direct current stimulation (tDCS)
on maximal voluntary isometric strength and endurance of the
elbow flexors
3.2.1 tDCS and sham interventions
Participants were unaware of the difference between the sham and tDCS
interventions, and did not report any adverse effects during and after interventions.
3.2.2 MVC
No significant difference in the baseline MVC strength (average: 66.0 ± 11.4 Nm)
was evident across the conditions. As shown in Table 1, MVC torque decreased by 4.3
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± 2.1 % from pre to post measurements, but no significant difference in change was
evident between interventions.
Table 3: Comparison between the measurements taken at baseline (Pre) and after either
sham or tDCS interventions (tDCS1, tDCS2) (Post) for maximal voluntary isometric
contraction strength (MVC) and time to failure in the 30%-MVC task (TTF). Mean ± SD
values of 15 subjects and the 95% confidence interval are shown. Differences between
Pre and Post assessed by a paired t-test (P values), effect size, and comparison between
interventions for the changes in the measures from Pre to Post based on a two-way
repeated measures ANOVA (P values) are shown when comparing among Sham, tDCS1
and tDCS2 (3 groups), and between Sham and tDCS1, Sham and tDCS2, and tDCS1
and tDCS2 (2 groups).

Pre

Post

Pre –
Post

mean ± SD
(95% CI)

mean ± SD
(95% CI)

(t-test,
P)

Sham

65.5 ± 12.2
(58.7 – 72.3)

62.2 ± 11.1
(56.1 – 68.4)

0.00

0.28

tDCS1

66.6 ± 11.3
(60.3 – 72.9)

62.0 ± 11.2
(55.8 – 68.2)

0.00

0.41

tDCS2

64.9 ± 11.3
(58.6 – 71.9)

62.0 ± 10.5
(56.2 – 67.8)

0.00

Sham

318.6 ± 90.9
(268.3 –
368.9)

Interventi
on

MVC
(Nm)

TTF
(s)

tDCS1

tDCS2

309.7 ± 93.7
(257.8 –
361.6)
308.7 ±
138.6
(231.9 –
385.5)

354.5 ±
144.8
(274.3 –
434.7)
328.8 ±122.4
(261.0 –
396.6)
325.7 ±
138.6
(248.9 –
402.5)

Effect
size

Comparison between
interventions
(2-way ANOVA, P)
3 groups

2 groups
Sham tDCS1

0.71

Sham tDCS2

0.14

0.27

tDCS1 tDCS2

0.08

0.08

0.30

Sham tDCS1

0.45

0.36

0.18

Sham tDCS2

0.35

0.29

0.12

tDCS1 tDCS2

0.93

0.15

0.60

3.2.3 TTF
As shown in Table 1, TTF did not change significantly from pre to post
measures, and no significant difference was found between interventions.
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3.2.4 Muscle activity and torque fluctuation
No significant changes in RMS amplitude were observed between baseline (0.29
± 0.14 mV) and post-intervention measures (0.30 ± 0.15 mV) for any of the sessions.
The torque fluctuation indicated by CV showed no significant difference across
interventions at the baseline measures (1.3 ± 0.6 %), and no significant change in CV
from the baseline was evident for the post-intervention measures (1.4 ± 0.6 %).

3.2.5 Pain perception
CR-10 showed a significant increase from pre (0.4 ± 0.5) to post TTF task (7.1 ±
1.5); however, no significant difference in the change was evident between
interventions.
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CHAPTER 4: DISCUSSION
Study 1 results showed that both within-day (separated by 60 min) and betweenday (separated by 1 week) reliability were acceptable for MVC and TTF tests. It should
be noted that MVC decreased significantly (P=0.000) from Trial 1 to Trial 2 by 5.9 ±
4.2 % with a 60 min rest between trials; however, when the measurement was taken one
week later, significant difference (P=0.000) was evident between tests (Table 2).
Cogiamanian et al. (2007) also reported a significant decrease in MVC of the elbow
flexors between trials separated by 60 min. This magnitude of significant decrease was
similar to that found in the reliability study. Hammer & Lindmark (2003) reported the
ability to repeat MVC of a grip force in both hands with stroke patients, having no
significant difference in trials performed one hour apart with complete rest in between.
This would suggest the likelihood of being normally able to replicate MVC outcomes
should there be complete rest. However, in the present study, additional isometric
contractions were included in the procedure (Figure 1). The decrease in MVC from the
first to the second trial was probably due to the sustained isometric contractions (3 x 10
s) and the time to failure test at 30% MVC that were performed after the MVC measures,
which induced neuromuscular fatigue. It is interesting that although the MVC was
lower in the second test, no significant difference in TTF was evident between the first
and second test separated by 60 min. This is different from the finding of Cogiamanian
et al. (2007) who showed a significant decrease in TTF in the second test by 40%
compared with the first test separated by 60 min. The lack of correspondence in results
could be due to the different position adopted to perform the elbow flexor tasks, the
difference in gender population and intensity of stimulation as well as the size of
electrodes used to deliver the intervention. Although the test-retest reliability is
acceptable for both MVC and TTF measures as shown in CV (4.3-10.9%), ICC R (0.84
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- 0.99) and Bland-Altman plots (Figure 8), a large variability exists for both measures
such that more than 10% difference in TTF between trials is occasionally found. This
should be considered when examining the effect of tDCS on TTF as discussed below.
The results of the present study showed no significant effects of tDCS
intervention on TTF and MVC, and other variables such as RMS, torque fluctuation and
pain perception. Thus the hypothesis that the tDCS intervention would increase TTF
and MVC was not supported by the results, and the present study did not replicate the
findings of the previous study by Cogiamanian et al. (2007) who reported a ~20%
difference in TTF between anodal tDCS and control conditions.
Test-retest reliability of the two TTF tests separated by 60 min or 1 week was
examined, and the results showed that the reliability of the TTF test was acceptable (CV
= 9-11%) and sensitive enough to detect a possible change in TTF that was reported in
the previous study (Cogiamanian et al. 2007). It should be noted that TTF did not
decrease from the pre to post intervention in the present study (Table 1), but the
previous study reported a significant decrease (20-35%) in TTF from the first to the
second test. MVC decreased by ~6% from pre to post intervention in the present study
(Table 1), and Cogiamanian et al. (2007) reported ~8% decrease in MVC between measures
separated by 60 min. In the present study, the target torque was set at 30% of MVC that was
measured immediately before the TTF task, but in the previous study (Cogiamanian et al.
2007), the target torque was set at 35% of baseline MVC. This may be the reason for no
significant decrease in TTF in the present study. In fact, TTF was longer for the present
study (average: >300 s) when compared to the previous study reporting a shorter TTF (e.g.
248 s before and 153 s after tDCS treatment).
The arm positions were different between the studies such that the present study had
upper arm resting on a preacher curl bench angled at 45° from the torso (Figure 2), but the
previous study had the participant’s upper arm in a vertical position and the forearm
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horizontally exerting an upward force. The position of the present study was adopted,
because it was deemed to reduce arm and shoulder movements during the MVC and TTF
measures thus improve the test-retest reliability. Rudroff et al. (2007) investigated the effect
of upper arm position on TTF, and reported that TTF was shorter when the upper arm
vertically positioned, as compared to when the arm was horizontally positioned. It is
possible that the longer TTF outcomes in present study suggest that the muscle endurance
task induced less fatigue, which attributed to the non-significant effect of tDCS on TTF.
Other differences between the two studies include the study design, gender of
participants, stimulation amplitude, and electrode placement. The present study used a
crossover design in which all subjects were tested for the tDCS and sham interventions in a
randomised, counterbalanced order, but the previous study (Cogiamanian et al. 2007) used
two groups of subjects (tDCS and Sham). Regarding the gender, the present study used only
men while the previous study used both men and women. Several studies reported that the
effects of tDCS intervention on cortical excitability was different between men and women
(Chaieb et al. 2008; Kuo et al. 2006), probably due to sex hormones such that estrogen was
found to increase cortical excitability (Inghilleri et al. 2004). It is also reported that women
are less fatigable and have longer TTF than men (Hunter et al. 2006; Yoon et al. 2007).
Thus, using men only in the present study was necessary to reduce potential gender effects.
It is necessary to replicate the study using female participants in future research, and it is
interesting to compare men and women for the effect of tDCS on MVC and TTF.
The present study delivered 2 mA in tDCS intervention, but the previous study used
1.5 mA. Jeffrey et al. (2007) reported that 2 mA tDCS stimulation when compared with 1
mA could penetrate deeper into the area controlling the leg muscles. The present study
followed this, and set the amplitude higher than that of the previous study, in the
assumption that the higher amplitude could increase the effect of tDCS on MVC and TTF,
if such effect exists. The present study used a smaller pair of electrode (24 cm2) as
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compared to the previous study (35cm2), because a smaller electrode would increase current
density (Nitsche et al. 2007), and minimise the possible effects on other areas due to less
focal stimulation with a larger electrode (Boros et al. 2008). This would suggest that a
larger electrode would affect not only the motor cortex but also the sensory cortex that is
located adjacent to the primary motor cortex. It is not known how the tDCS protocol
affected the sensory cortex in the present study, but no significant changes in pain
perception may suggest that the tDCS did not affect sensory cortex. Boggio et al. (2008b)
reported that pain perception and pain threshold increased after applying anodal tDCS to the
motor cortex. It is interesting to examine if applying tDCS on the sensory cortex affects
MVC and TTF outcomes.
tDCS is known to alter firing rates of motor neurons due to a shift of resting
membrane potentials (Purpura and McMurtry 1965). It is assumed that anodal tDCS
intervention can increase motor unit recruitment due to the depolarisation of resting
membrane potentials of neurons (Liebetanz et al. 2002) and corticospinal excitability
(Nitsche and Paulus 2000). Christou & Carlton (2002) stated that increases in discharge
rates of motor units induce fluctuations of motor output, and increased the amplitude of
force fluctuation during voluntary contractions, suggesting an increase in motor unit
recruitment. Current results showed no changes in torque fluctuation before and after either
treatment. Likewise, muscle activity of the elbow flexor muscles, as reflected in EMG RMS,
also showed no changes with sham and tDCS intervention. Thus, it seems reasonable to
assume that tDCS did not affect motor unit recruitment in the present study.
When maximal voluntary activation is possible, tDCS would not further increase
voluntary activation, suggesting a ceiling effect at corticospinal levels. Tanaka et al. (2009)
did not find any effects of anodal tDCS over the leg motor cortex on contralateral reaction
time, and explained that this was due to performance ceiling such that the reaction time was
already quite short before the intervention. Antal et al. (2006) reported no effects of anodal
tDCS on visual perception and stated that no effect was probably due to a ceiling effect; the
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visual perception could not be improved further by tDCS. Moreover, Hummel et al. (2006)
showed greater improvement in dexterity performance with anodal tDCS in stroke patients
who had higher levels of impairment than those found with lower levels. This would
suggest the more inhibited the motor cortex is, the greater the effects of tDCS on increasing
voluntary activation. It is possible that when cortical excitability is decreased due to

central fatigue for example, tDCS can increase cortical excitability or decrease fatigue
perception, resulting in improving muscle function. This speculation should be
investigated further by checking the effect of tDCS on muscle function in different levels of
cortical excitability.

In conclusion, the 10-min anodal tDCS at 2 mA did not affect TTF and MVC of
the elbow flexors. It appears that the tDCS was not effective when muscle function is
not decreased due to central fatigue. It may be that a tDCS intervention does not
increase muscle function when it is possible to maximise cortical excitability voluntarily.
Since the present study did not assess MEP that could show changes in cortical
excitability following tDCS or sham treatment, further studies are required to examine
the effects of tDCS on cortical excitability.
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APPENDIX B – INFORMATION LETTER: STUDY 1

Information Letter
For Study 1 of

Reliability of 30% and 100% Maximum voluntary
isometric contraction (MVIC) “time-to-failure” tasks
Investigator: Benjamin Kan
Supervisor: Prof Ken Nosaka
School of Exercise, Biomedical and Health Sciences
Edith Cowan University
270 Joondalup Drive, Joondalup WA 6027
Phone: 6304-2264
email: b.kan@ecu.edu.au

Thank you for expressing your interest in this research.
The purpose of this information sheet is to provide you with an overview of the study
that you may participate in as a subject.
Please read the following information carefully and feel free to ask for any further
explanation, should you have any other doubts or enquiries.
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Purpose of study
The purpose of this study is to find out if muscle endurance time of the elbow flexor
muscles (biceps) is similar between tests separated by 1 hour and 1 week. You are
required to performed a muscle endurance test; being a 30% effort, and maximal effort
contractions of the bicep muscles as shown below. You will be asked to maintain the
endurance task for as long as possible, and the time that you can maintain the
contraction will be measured.

Description of study
If you agree to participate in this study, you will be asked to come to the Exercise
Physiology Laboratory (Joondalup campus, Building 19.150) on 3 separate occasions
consisting of 1 familiarisation session and 2 experimental sessions. All sessions will be
scheduled over 3 consecutive weeks with one week between sessions and each session
will take approximately 1.5 hours or less.

Familiarisation session
During the familiarisation session, you will be shown the muscle endurance tasks
performed at the two required intensities, as well as all experimental procedures. You
will be performing the endurance task with both a 30% effort and also maximal effort
contractions to help familiarize you on how to perform the task best.
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Experimental sessions
There will be in total 3 experimental sessions. During the first two sessions, you will be
required to perform a 30% effort produced at the bicep muscles, and hold it for as long
as you can till you reach failure (point at which you can no longer maintain the required
intensity). In each session, the designated muscle endurance task will be performed
twice with 60 minutes rest in between.

Muscle endurance tasks
You will be seated on a preacher curl bench, with your forearm of the non-dominant
arm set at 90º strapped securely to a Cybex 6000 isokinetic dynamometer (Lumex Inc.
Ronkonkoma, USA). This machine sends the force output signals to a computer which
indicates your force generated on a computer screen, and will act as a feedback for you.
While seated on the preacher curl bench, you will be requested to perform two bouts of
muscle endurance tasks at the elbow flexor muscles of the non-dominant hand, with 60
minutes of rest between the two bouts. This muscle endurance task is also known as a
“time-to-failure” task, whereby the time point in which you are unable to hold the
contraction any longer, will be determined from these tests. The intensity at which the
task is to be performed will be either fixed at 30% of your maximal effort or at maximal
effort.

Measurements
The following measurements will be taken during the course of each session in the
following order.
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1. Maximal voluntary contraction (MVC) and muscle endurance task
You will be required to perform three 3 seconds maximal bicep curl contractions with
60 seconds rest between each trial. After a 60 seconds rest period you will be required
to perform 2 bouts of the 30% effort endurance task or 100% effort endurance task as
shown below.

30% effort endurance task
You will be required to perform the endurance task at 30% effort for a minimum of 150
seconds or till failure. Failure is determined by the torque levels, when you are unable to
maintain the required force for 2 seconds. You will be given 60 minutes of rest before
repeating the muscle endurance test.

Requirements and Benefits
You will be asked to report to the laboratory as explained above. You will be requested
not to be involved in any form of upper body training, exercises or activities involving
the elbow flexors muscles during the course of this study. Prior to testing days, you are
to refrain from any form of strenuous activity for at least 24 hours. Caffeine
consumption is not allowed for at least 4 hours prior to the test. Should you not feeling
well or are on any medication, do let the investigator know and other arrangements
could be made.
Your participation is greatly appreciated as it helps us to know whether muscle
endurance time is similar between tests. If so, interventions can be introduced to help
increase endurance outcomes. You will also understand the research topic and methods
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used in this study. We are most happy to provide some information associated with this
study upon your request.

Risk and Ethical Considerations
You may experience a small degree of muscle soreness, at the elbow flexors, following
the testing days, all of which should subside by the second day or so. This is often seen
after any form of unaccustomed exercise containing concentric muscle actions. No
direct comparisons between individuals participating in the study will be made at any
stage of the testing. You are therefore not in competition with any other individual in
the study and will in no way be made to feel that your results are inadequate or incorrect.
All personal information and test results will remain confidential and will not be used to
any purpose other than the current study. Moreover, no data analysis will include your
name or information that may identify you specifically as a subject. You will also be
free to withdraw from this study at any stage and for any reason without prejudice.

Medical Questionnaire
As this study involves a testing protocol, it is required that you be healthy at the time of
testing. For this reason you will be asked to complete a medical questionnaire prior to
the commencement of testing. Answering ‘Yes’ to a question will not always disqualify
you from participation in the study. However you may be asked to consult your doctor
for clearance prior to participation.

Questions / Further Information
This project has been approved by the ECU Human Research Ethics Committee. It is
intended to present the results of this research through conferences and publish journals
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and reports. Published results will not contain information that can be used to identify
participants unless specific consent for this has been obtained. A copy of published
results may be obtained by the participants upon requests.

If you have read and understood the description of this study and wish to volunteer as a
subject, the next step is to sign the informed consent form. By signing this form you
acknowledge that you are aware of the procedures, tests and risks involved. You remain
free to withdraw from the study at any time for whatever reason; signing the informed
consent form does not remove your rights to withdraw from this study.

Should you have any questions relating to any of the information provided above,
please feel free to contact me for a further explanation. If you have any concerns about
this research, or would like to speak to an independent person, you may contact:
Research Ethics Officer
Human Research Ethics Committee,
Edith Cowan University
270 Joondalup Drive
Joondalup WA 6027
Phone: (08) 6304 2170
Email: research.ethics@ecu.edu.au

Thank you for taking time to read this information letter. If you have any questions or
require any further information about this project, please contact Benjamin Kan
(b.kan@ecu.edu.au).
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Investigator: Benjamin Kan (MSc Candidate)

Signature: _____________________________

Date:

/

/

_
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APPENDIX C – INFORMATION LETTER: STUDY 2

Information Letter
For Study 2 of

Effects of Transcranial Direct Current Stimulation (tDCS) on
corticomotor excitability and muscular endurance of the elbow flexors.

Investigator: Benjamin Kan
Supervisor: Prof Ken Nosaka
School of Exercise, Biomedical and Health Sciences
Edith Cowan University
270 Joondalup Drive, Joondalup WA 6027
Phone: 6304-2264
email: b.kan@ ecu.edu.au
Thank you for expressing your interest in this research.
The purpose of this information sheet is to provide you with an overview of the study
that you may participate in as a subject.
Please read the following information carefully and feel free to ask for any further
explanation, should you have any other doubts or enquiries.
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Purpose of study
The purpose of this study is to investigate how electrical stimulation to your brain
affects your muscle endurance.

This electrical stimulation technique is called

transcranial direct current stimulation (tDCS), whereby a very weak electrical current (2
milli amperes [mA], which is about the intensity of a 1.5v battery) is delivered and
applied to the surface of the scalp via electrodes. There are two electrodes used, the
positive electrode also known as the “anode”, and the negative electrode otherwise
known as the “cathode”. The methods of tDCS we are using is known as anodal tDCS,
whereby the anode is placed on the scalp to deliver the electrical current. Although this
method of tDCS treatment has been used clinically with patients who suffer from
depression, epilepsy and chronic pain, little is known about the effect of tDCS on
muscle function, especially on muscle endurance of the elbow flexors. This study will
examine the effect of 10 minutes of anodal tDCS applied to the scalp, on muscle
endurance of the bicep muscle, by applying a 30% effort and holding and enduring that
contraction for as long as possible, together with its effect on excitability of your brain,
your fatigue perception, brain and muscle oxygen levels

Description of study
If you agree to participate in this study, you will be asked to come to the Exercise
Physiology Laboratory (Joondalup campus, Building 19.150) on 4 separate occasions
consisting of 1 familiarisation session and 3 experimental sessions. All sessions will be
scheduled over 4 consecutive weeks with one week between sessions.
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Familiarization session
During the familiarisation session, you will be shown two muscle endurance tasks and
all experimental procedures. Weak electric current of tDCS treatment will also be
applied to the scalp for approximately 30 seconds. This is to familiarize you with the
weak intensity of current used during actual experimental sessions.

Experimental sessions
For the 3 experimental sessions, you will perform either a 30% effort of your maximal
strength produced at the bicep muscles and hold it for as long as you can. In each
session, the designated muscle endurance task will be performed twice with a 60
minutes rest in between. During the last 10 minutes of the 60 minutes rest period, tDCS
will be applied to your scalp for 10 minutes. Measurements of brain excitability will be
taken before and after tDCS application as described below. All sessions will take
approximately 1.5 hours or less.

Muscle endurance tasks
You will be seated on a preacher curl bench, with your forearm of the non-dominant
arm set at 90º strapped securely to a Cybex 6000 isokinetic dynamometer (Lumex Inc.
Ronkonkoma, USA). This machine then send the force output signals to computer
screen which indicates your force generated, and will act as a feedback for you. While
seated on a preacher curl bench, you will be requested to perform two bouts of muscle
endurance tasks at the elbow flexor muscles of the non-dominant hand, with 60 minutes
of rest between the two bouts. The muscle endurance task will be either at 30% effort of
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your maximal force produced, or a maximal strength endurance test, the “time-to-failure”
will be determined from these tests.

Transcranial direct current stimulation (tDCS)
Weak tDCS electric currents will be delivered via a pair of electrodes, with the positive
electrode (anode) placed on the surface of the scalp, over where the motor cortex lies
which controls the non dominant hand, and the cathode placed over the shoulder of the
same side of where the electrode is placed. Stimulating electrodes will be a pair of 0.3
cm thick square (35cm2) sponge electrodes soaked with saline, which helps conductivity
of the electric currents and to reduce any irritation to the skin during treatment There is
no known side effect to tDCS so far but it has only been reported that a very slight
tingly sensation can be felt initially for the first 30 seconds or less which then fades
away. This tingly sensation occurs due to your skin sensing a change in electrical field
when either slowly increasing or decreasing the intensity of electric current. Once the
required intensity of 2mA (this intensity is similar to that of a normal AA battery) or
ramping down to 0mA has been reached, the skin does not feel anymore changes in
electric current (as intensity in current has stabilized) the tingly sensation disappears
instantaneously.

Measurements
The following measurements will be taken during the course of each session in the
following order.

1. Muscle Activity
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Muscle activity of the biceps and triceps brachii is recorded by the use of
electromyography. After swabbing the skin with alcohol, electrodes will be placed on
the muscle belly and tendon of the biceps and triceps, to detect your muscle activity.
This will tell us if muscle activation is altered with tDCS.

2. Maximal voluntary contraction (MVC) and muscle endurance task
You will be required to perform three 3-second maximal bicep curl contractions with 60
seconds of rest between each trial. After a 60 second rest period, you will be required to
perform 2 bouts of the 30% effort endurance task or 100% effort endurance task as
shown below.

30% effort endurance task
You will be required to sustain a 30% effort endurance task for a minimum of 150
seconds or till failure that is determined by the torque levels, when you are unable to
maintain the required force for 2 s. You will be given 60 minutes of rest before
repeating the muscle endurance test. However 50 minutes into the rest period, tDCS
treatment will be applied for 10 minutes. Immediately after the tDCS treatment, both
MVC and the muscle endurance task will be performed again.

3. Pain / Fatigue perception
You will be asked to indicate your perception of pain / fatigue and exertion or alertness
before and during the tests (i.e. after muscle endurance tests, before and after tDCS)
using a Borg category-ratio 10 (CR-10) RPE scale . The scale consists of 1 to 10 where
1 represents very little pain / effort exerted and 10 represents an extremely pain / strong
effort exerted.
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Requirements and Benefits
You will be asked to report to the laboratory as explained above. You will be requested
not to be involved in any form of upper body training, exercises or activities involving
the elbow flexors muscles during the course of this study. Prior to testing days, you are
to refrain from any form of strenuous activity for at least 24 hours. Caffeine
consumption is not allowed for at least 4 hours prior to the test. Should you not feeling
well or are on any medication, do let the investigator know and other arrangements
could be made.
Your participation is greatly appreciated as it helps us to understand how tDCS might
help muscular endurance and would open doors to explore and investigate the
underlying mechanisms behind it.
You will understand the research topic and methods used in this study. We are most
happy to provide more information associated with this study upon your request.

Risk and Ethical Considerations
Application of tDCS is safe and is currently used to patients suffering from depression,
epilepsy and also chronic stroke. There has been no side effects of tDCS reported but
has only been reported that during stimulation, a light tingling sensation can be felt on
the skin below the electrodes which will disappear within 30 s or so (as explained in
detail above). You may experience a small degree of muscle soreness, at the elbow
flexors, following the testing days, all of which should subside by the second day or so.
This is often seen after any form of unaccustomed exercise containing concentric
muscle actions. No direct comparisons between individuals participating in the study
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will be made at any stage of the testing. You are therefore not in competition with any
other individual in the study and will in no way be made to feel that your results are
inadequate or incorrect. All personal information and test results will remain
confidential and will not be used to any purpose other than the current study. Moreover,
no data analysis will include your name or information that may identify you
specifically as a subject. You will also be free to withdraw from this study at any stage
and for any reason without prejudice.

Medical Questionnaire
As this study involves stimulation of the brain and the use of magnetism for taking
measurements, there are various factors which may exclude your from participation in
this study. These include having a pacemaker or metal objects like cerebral aneurysm
clips inside your body. Additionally, as this study involves a testing protocol, it is
required that you be healthy at the time of testing. For this reason you will be asked to
complete a medical questionnaire prior to the commencement of testing. Answering
‘Yes’ to a question will not always disqualify you from participation in the study.
However you may be asked to consult your doctor for clearance prior to participation.

Questions / Further Information
This project has been approved by the ECU Human Research Ethics Committee. It is
intended to present the results of this research through conferences and publish journals
and reports. Published results will not contain information that can be used to identify
participants unless specific consent for this has been obtained. A copy of published
results may be obtained by the participants upon requests.

44

If you have read and understood the description of this study and wish to volunteer as a
subject, the next step is to sign the informed consent form. By signing this form you
acknowledge that you are aware of the procedures, tests and risks involved. You remain
free to withdraw from the study at any time for whatever reason; signing the informed
consent form does not remove your rights to withdraw from this study.

Should you have any questions relating to any of the information provided above,
please feel free to contact me for a further explanation. If you have any concerns about
this research, or would like to speak to an independent person, you may contact:
Research Ethics Officer
Human Research Ethics Committee,
Edith Cowan University
270 Joondalup Drive
Joondalup WA 6027
Phone: (08) 6304 2170
Email: research.ethics@ecu.edu.au

Thank you for taking time to read this information letter. If you have any questions or
require any further information about this project, please contact Benjamin Kan
(b.kan@ecu.edu.au).
Investigator: Benjamin Kan (MSc Candidate)

Signature: _____________________________

Date:

/

/

_
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APPENDIX D – INFORMED CONSENT FORM: STUDY 1

Informed Consent Document
Title of Study:

Reliability of 30% and 100% Maximum voluntary isometric contraction (MVIC)
“time-to-failure” tasks
Researcher (contact details)
Investigator:
Benjamin Kan
Tel: 6304 – 2264,
Email: b.kan@ecu.edu.au
Supervisor:
Professor Ken Nosaka
Tel: 6304 – 5655
Email: k.nosaka@ecu.edu.au
School of Exercise, Biomedical and Health Sciences
Faculty of Computing, Health and Science
Edith Cowan University
270 Joondalup Drive, Joondalup WA 6027, Australia

Indication of consent of participation
I confirm the following:
•
•
•
•
•
•
•
•
•

I have been provided with clear information as given in the “Information letter”, which
explains all the procedures of the study.
I have read and understood the information provided and the possible risks involved while
participating in the study.
I have been given ample opportunity to enquire on my doubts and questions and I have
been answered adequately.
I am aware that should there be any further questions and doubts, I can contact the
research team.
I understand the requirements and instructions of the study as clearly mentioned in the
“Information letter”.
I understand that the information I provide will be kept confidential and my identity will not
be disclosed without prior consent.
I understand the information provided will only be used for the purposes of this research
project, and I understand how the information will be used.
I understand that I am free to withdraw from further participation at anytime without any
given explanation or penalty.
I give my full consent and agree to participate in this study.

Signature: ___________________________

Investigator’s Signature
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Name:_______________________________
_____________________________

Date: ________________
________________

Date:

Contact: _____________________________
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APPENDIX E – INFORMED CONSENT FORM: STUDY 2

Informed Consent Document
Title of Study:
Effects of transcranial direct current stimulation (tDCS) on corticomotor excitability and
muscular endurance of the elbow flexors
Researcher (contact details)
Investigator:
Benjamin Kan
Tel: 6304 – 2264,
Email: b.kan@ecu.edu.au
Supervisor:
Professor Ken Nosaka
Tel: 6304 – 5655
Email: k.nosaka@ecu.edu.au
School of Exercise, Biomedical and Health Sciences
Faculty of Computing, Health and Science
Edith Cowan University
270 Joondalup Drive, Joondalup WA 6027, Australia

Indication of consent of participation
I confirm the following:

•
•
•
•
•
•
•
•

I have been provided with clear information as given in the “Information letter”,
which explains all the procedures of the study.
I have read and understood the information provided and the possible risks involved
while participating in the study.
I have been given ample opportunity to enquire on my doubts and questions and I
have been answered adequately.
I am aware that should there be any further questions and doubts, I can contact the
research team.
I understand the requirements and instructions of the study as clearly mentioned in
the “Information letter”.
I understand that the information I provide will be kept confidential and my identity
will not be disclosed without prior consent.
I understand the information provided will only be used for the purposes of this
research project, and I understand how the information will be used.
I understand that I am free to withdraw from further participation at anytime without
any given explanation or penalty.
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•
•

I agree to be treated with Transcranial Direct Current Stimulation (tDCS) and I also
understand that tDCS is safe and has no side effects on me, and the investigator has
been trained in all aspects of the delivery of safe tDCS.
I give my full consent and agree to participate in this study.

Signature: ___________________________

Investigator’s Signature

Name:_______________________________
_____________________________

Date: ________________

Date: ________________

Contact: _____________________________
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APPENDIX F – MEDICAL QUESTIONAIRE

Pre-Exercise Medical Questionnaire
The following questionnaire is designed to establish a background of your medical
history, and identify any injury and/ or illness that may influence your testing and
performance. If you are under 18 then a parent or guardian should complete the
questionnaire on your behalf or check your answers and then sign in the appropriate
section to verify that they are satisfied the answers to all questions are correct to the best
of their knowledge.
Please answer all questions as accurately as possible, and if you are unsure about
anything please ask for clarification. All information provided is strictly confidential.

Personal Details
Name:______________________________________________
Date of Birth (DD/MM/YYYY):__________________

Gender: Female/ Male

PART A
1. Are you a male over 45 yr, or female over 55 yr or who has had a hysterectomy or
are postmenopausal?
Yes No
If YES, please provide details
2.

Are you a regular smoker or have
_______________
quit in the last 6 months?

3.

4.

you

Y

N

Did a close family member have heart
_______________
disease or surgery, or stroke before the age
of 60 years?

Y

N

Unsure

Do you have, or have you ever been
_______________
told you have blood pressure above
140/90 mmHg, or do you current take
blood pressure medication?

Y

N

Unsure
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5.

Do you have, or have you ever been
_______________
told you have, a total cholesterol level
above 5.2 mmol/L (200 mg/dL)?

Y

N

Unsure

6.

Is your BMI (weight/height2) greater
_______________
than 30 kg/m2?

Y

N

Unsure

PART B
1.

Have you ever had a serious asthma
_____________________
attack during exercise?

Y

N

2.

Do you have asthma that requires
_____________________
medication?

Y

N

3.

Have you had an epileptic seizure in
_____________________
the last 5 years?

Y

N

4.

Do you have any moderate or severe
_____________________
allergies?

Y

N

5.

Do you, or could you reasonably, have
_____________________
an infectious disease?

Y

N

6.

Do you, or could you reasonably, have
_____________________
an infection or disease that might be
aggravated by exercise?

Y

N

7.

Are you, or could you reasonably be,
_____________________
pregnant?

Y

N
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PART C
1. Are you currently taking any prescribed or non-prescribed medications?
Y

N

_____________________
2. Have you had, or do you currently have, any of the following?
If YES, please provide details
Rheumatic fever
_____________________

Y

N

Heart abnormalities
_____________________

Y

N

Diabetes
_____________________

Y

N

Epilepsy
_____________________

Y

N

Recurring back pain that would make
_____________________
exercise problematic, or where exercise
may aggravate the pain

Y

N

Recurring neck pain that would make
_____________________
exercise problematic, or where exercise
may aggravate the pain

Y

N

Any neurological disorders that would
_____________________
make exercise problematic, or where
exercise may aggravate the condition

Y

N

Any neuromuscular disorders that would
_____________________
make exercise problematic, or where
exercise may aggravate the condition
Recurring muscle or joint injuries that
_____________________
would make exercise problematic, or
where exercise may aggravate the condition

Y

N

Y

N

Y

N

A burning or cramping sensation in your
_____________________
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legs when walking short distances
Chest discomfort, unreasonable
_____________________
breathlessness, dizziness or fainting,
or blackouts during exercise

Y

N

Have you had flu in the last week?
_____________________

Y

N

Do you currently have an injury that might
_____________________
affect, or be affected by, exercise?

Y

N

1. Have you had Transcranial Direct Current
_____________________
Stimulation (tDCS) / Transcranial Magnetic
Stimulation (TMS) before? If ‘Yes’, have
you been tested in the last 6 months?

Y

N

2. Have you participated in an upper body
_____________________
resistance training program in the last month?

Y

N

3. Do you have any neurological disorders?
_____________________

Y

N

4. Do you have any neuromuscular disorders?
_____________________

Y

N

5. Have you ever had cardiac surgery?
_____________________
i.e. valve replacement, pacemaker. If ‘Yes”,
provide details.

Y

N

6. Have you ever had ear surgery?
_____________________
i.e. cochlear implants, hearing aid. If ‘Yes”,
provide details.

Y

N

7. Have you ever had brain surgery?
_____________________
i.e. shunt, aneurysm clip. If ‘Yes”,
provide details.

Y

N

PART D

PART E
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8. Do you have any history of severe migraines?
_____________________

Y

N

9. Do you have ay surgically implanted foreign
_____________________
objects in your body? If ‘Yes”,
provide details.

Y

N

10. Are you aware that you should talk to your
_____________________
doctor about your participation in this study if
you have a mental illness or disorder?

Y

N

*Is there any other condition not previously mentioned that may affect your ability to
participate in this study?
Y
N
_________________________________________________________

Declaration (to be signed in the presence of the researcher)
I acknowledge that the information provided on this form, is to the best of my
knowledge, a true and accurate indication of my current state of health.

Participant
Name:________________________

Date (DD/MM/YYYY):_______________

Signature:____________________________

Researcher:
Name: ________________________________
Signature:_____________________________
Date (DD/MM/YYYY):_________________

________________________________________
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Parent/ Guardian (only if applicable)
I, ______________________________________________, as parent / guardian of
Mr/ Miss _____________________________________________, acknowledge
that I have checked the answers provided to all questions in the medical
questionnaire and verify that they are correct to the best of my knowledge.
Signature: ____________________________________
Date (DD/MM/YYYY): _________________________

Practitioner (only if applicable)
I, Dr _______________________________________ have read the medical
questionnaire and information/ consent form provided to my patient Mr/Miss/
Ms____________________________________, and clear him/ her medically for
involvement in exercise testing.
Signature:____________________________________
Date (DD/MM/YYYY):_________________________
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APPENDIX G –HANDEDNESS INVENTORY
Edinburgh Handedness Inventory1
Your Initials:
Please indicate with a check () your preference in using your left or right hand in the
following tasks.
Where the preference is so strong you would never use the other hand, unless absolutely
forced to, put two checks ().
If you are indifferent, put one check in each column (  | ).
Some of the activities require both hands. In these cases, the part of the task or object
for which hand preference is wanted is indicated in parentheses.
Task / Object

Left Hand

Right Hand

1. Writing
2. Drawing
3. Throwing
4. Scissors
5. Toothbrush
6. Knife (without fork)
7. Spoon
8. Broom (upper hand)
9. Striking a Match (match)
10. Opening a Box (lid)
Total checks: LH =

RH =

Cumulative Total CT = LH + RH =
Difference D = RH – LH =
Result R = (D / CT) × 100 =
Interpretation:
(Left Handed: R < -40)
(Ambidextrous: -40 ≤ R ≤ +40)
(Right Handed: R > +40)
1

Oldfield, R. C. (1971). The assessment and analysis of handedness: The Edinburgh
inventory. Neuropsychololgia, 9, 97-113.
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APPENDIX H– ETHICS APPROVAL
Dear Benjamin
Project Number: 4021
Project Name: Effect of transcranial direct current stimulation (tDCS) on
corticomotor excitability and muscular endurance
Ethics approval for your research project was granted from 17 November 2009 to 31
July 2011.
The National Statement on Ethical Conduct in Human Research requires that all
approved projects are subject to monitoring conditions. This includes completion of an
annual report (for projects longer than one year) and completion of a final report at the
end of the project.
An ANNUAL REPORT is due on 17 November 2010.
A copy of the ethics report form can be found on the Ethics Website
Please complete the ethics report form and return the signed form.
Regards
Kim
Kim Gifkins
Research Ethics Officer
Edith Cowan University
270 Joondalup Drive
JOONDALUP WA 6027
Phone: (08) 6304 2170
Fax:
(08) 6304 5044
Email: research.ethics@ecu.edu.au

57

